about
Biological and immunological characteristics of lipooligosaccharide-based conjugate vaccines for serotype C Moraxella catarrhalisChanges in pharyngeal aerobic microflora in oral breathers after palatal rapid expansionA major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model.Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis.Moraxella catarrhalis: from emerging to established pathogen.Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30-center national surveillance study.Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United StatesIn vitro activities of 39 antimicrobial agents for Branhamella catarrhalis and comparison of results with different quantitative susceptibility test methodsDisk diffusion susceptibility testing of Branhamella catarrhalis with ampicillin and seven other antimicrobial agentsAntimicrobial susceptibility testing of Haemophilus influenzae, Branhamella catarrhalis, and Neisseria gonorrhoeae.Disk diffusion susceptibility of Branhamella catarrhalis and relationship of beta-lactam zone size to beta-lactamase production.Purification and characterization of a high-molecular-weight outer membrane protein of Moraxella (Branhamella) catarrhalisComparative immunochemistry of lipopolysaccharides from Branhamella catarrhalis strains.Selective medium with DNase test agar and a modified toluidine blue O technique for primary isolation of Branhamella catarrhalis in sputum.Wound infection caused by Branhamella catarrhalis.Branhamella infections. An increasingly common respiratory illness.Adenovirus serotype 1 does not act synergistically with Moraxella (Branhamella) catarrhalis to induce otitis media in the chinchillaSurface-exposed and antigenically conserved determinants of outer membrane proteins of Branhamella catarrhalis.Interpretation of gram-stained sputa containing Moraxella (Branhamella) catarrhalis.Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum.Detection of beta-lactamase activity among clinical isolates of Branhamella catarrhalis with six different beta-lactamase assays.Effect of inoculum size on results of macrotube broth dilution susceptibility tests with Branhamella catarrhalis.The major heat-modifiable outer membrane protein CD is highly conserved among strains of Branhamella catarrhalis.Children with persistent cough--outcome with treatment and role of Moraxella catarrhalis?Possible relationship of PFGE patterns of Moraxella catarrhalis between hospital- and community-acquired respiratory infections in a community hospital.Significance of isolation of Moraxella catarrhalis in routine cultures from the respiratory tract in adults: antibody response studied in a whole cell EIA.Treatment of Sinus Empyema in Adults: A Coordinated Nordic Multicenter Trial of Cefixime vs. Cefaclor
P2860
Q24684942-0AE4C779-633E-4926-B853-F99D5848549FQ25257752-34E6730E-8BC9-41AA-B40C-C9B3968184BFQ33596480-3D90D51A-AF1E-4707-8AB1-6D1EE4C3D256Q33753424-B8915B19-E78F-4503-86AB-CB39D739200EQ33906182-88E32B4D-7164-41B8-9396-63FD5A7046AEQ35130432-E0BEF222-ED4C-4737-B039-7C62C0E43685Q35280150-AC9A34AB-F27F-46B9-B487-3A09F7E9BB49Q35292464-EB17CD67-DFEB-4D4B-816C-37C332F5395CQ35542318-CCA9D075-5BD4-4859-AA26-F39B7C40EF44Q35565622-9B4D981C-C1CA-4C59-A8BD-39351D66483FQ35575739-8F1EA48D-D077-48C7-9165-124BB3F65A43Q35775861-BD70D29B-1DF8-4E42-8715-E9CA3EFFEC3EQ36969163-7B10E4F5-A8D7-48D4-8E99-4E4BFCC24678Q37144691-66C99CD7-CC90-48E4-87BA-EA7141BF69A3Q37172281-8A7F560E-5F2B-44A6-B043-3194D338F21BQ38221630-22206F3D-9234-4C3A-935E-FEFA3CA2FCDDQ39823299-53226E0A-9475-4B82-86EC-AB9566EB947AQ40164432-1C80BE10-1D84-4406-B322-13139710EFE9Q40203150-5B3B1FD6-0658-4995-9686-8EC3C2B67698Q40203307-8273D590-6114-4BAA-93A0-0E1585AEE0C4Q40208397-E1A611C3-65A4-490B-988F-CB9CEE46431FQ40208663-9C5937B6-1AD5-4A6F-A34E-9E06F42A70FCQ42594762-BC68B342-414C-4533-9BB6-827D8A047112Q44169354-87DFAA56-D239-4C93-9B5D-79A6805C65ADQ51659973-44A2282B-D8C1-468C-BBA5-85EC50864946Q54221885-4AB99EF5-6060-43F9-8EE9-339A09651ED3Q58255276-55C5F5CF-C04B-4BEA-B135-20A9A8929F15
P2860
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Branhamella catarrhalis--an emerging human pathogen.
@en
Branhamella catarrhalis--an emerging human pathogen.
@nl
type
label
Branhamella catarrhalis--an emerging human pathogen.
@en
Branhamella catarrhalis--an emerging human pathogen.
@nl
prefLabel
Branhamella catarrhalis--an emerging human pathogen.
@en
Branhamella catarrhalis--an emerging human pathogen.
@nl
P1476
Branhamella catarrhalis--an emerging human pathogen.
@en
P2093
P304
P356
10.1016/0732-8893(86)90098-2
P577
1986-03-01T00:00:00Z